CASI Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-39.26	-26.26	-40.26	-35.84	-47.51
Depreciation & Amortization	3.45	4.73	3.61	3.1	3.23
Stock-Based Compensation	1.31	7.22	7.01	7.77	7.82
Other Adjustments	4.51	2.16	15.2	1.35	13.89
Change in Receivables	-5.79	3.42	-3.17	-5.16	-3.35
Changes in Inventories	5.83	-9.74	-4.23	-0.55	3.19
Changes in Accounts Payable	-1.72	1.15	1.07	1.49	-1.54
Changes in Accrued Expenses	1.55	-0.88	-0.91	2.3	-1.43
Changes in Income Taxes Payable	-	-1.89	1.98	-	-
Changes in Other Operating Activities	0.91	0.11	-1.38	-1.3	-0.18
Operating Cash Flow	-29.22	-19.97	-21.09	-26.84	-25.89
Capital Expenditures	-0.22	-0.2	-5.61	-8.95	-1.5
Sale of Property, Plant & Equipment	-	-	0.14	0.01	-
Purchases of Intangible Assets	-0.02	-2.04	-	-6.64	-17.83
Proceeds from Sale of Intangible Assets	0.5	-	-	-	2.7
Purchases of Investments	-2.78	-51.75	-7.43	-5.33	-6.4
Proceeds from Sale of Investments	13.76	44.32	37.62	-0.26	-
Other Investing Activities	-	-	6.44	0.47	2.31
Investing Cash Flow	11.24	-9.67	31.16	-20.69	-20.72
Short-Term Debt Issued	-	-	-	-	0.47
Net Short-Term Debt Issued (Repaid)	-	-	-	-	0.47
Long-Term Debt Issued	-	-	4	0.71	0.78
Long-Term Debt Repaid	-	-	-4	-1.55	-
Net Long-Term Debt Issued (Repaid)	-	-	-	-0.84	0.78
Issuance of Common Stock	17.11	0.11	-	32.5	48.97
Repurchase of Common Stock	-	-0.28	-3.27	-2.02	-0.25
Net Common Stock Issued (Repurchased)	17.11	-0.17	-3.27	30.48	48.72
Other Financing Activities	-1.68	-0.74	-	-	-2.82
Financing Cash Flow	15.43	-0.91	-3.27	29.64	47.15
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-1.07	0.52	1.6	-0.47	2.9
Net Cash Flow	-3.62	-30.03	8.41	-18.36	3.44
Beginning Cash & Cash Equivalents	17.08	47.11	38.7	57.06	53.62
Free Cash Flow	-29.45	-20.17	-26.7	-35.79	-27.39
FCF Margin	-103.19%	-59.54%	-61.94%	-118.63%	-180.87%
Free Cash Flow Per Share	-	-1.51	-1.96	-2.63	-2.48
Levered Free Cash Flow	-29.47	-33.68	-46.5	-41.4	-45.27
Unlevered Free Cash Flow	-29.83	-31.72	-41.31	-45.43	-51.02

Updated Dec 31, 2024. Data Source: Fiscal.ai. Standard template. Financial Sources.